These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2004-000919-26 Phase II, randomized, pharmokinetic, dose finding, and dose frequency determination using rt-PA in intraventricular hemorrhage 2008-08-21 bad-data
Not reported 2007-006006-22 Minimally Invasive Surgery plus rt-PA for ICH Evacuation 2014-09-02 due-trials
No trial status on register 2008-005571-10 DEXTROMETORPHAN IN RETT SYNDROME bad-data
Listed as ongoing, but also has a completion date 2008-006916-39 CLEAR III. Clot lysis: evaluating accelerated resolution of intraventricular hemorrhage 2016-02-05 bad-data
Listed as ongoing, but also has a completion date 2013-002818-12 A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral haemorrhage. 2018-09-17 bad-data
Exempt 2013-003184-62 A phase I study of SGI-110 combined with irinotecan followed by a randomized phase II study of SGI-110 combined with irinotecan versus regorafenib in previously treated metastatic colorectal cancer pa... not-yet-due
Ongoing 2013-005086-40 A multi-institutional open label, trial evaluating the efficacy of Gemcitabine and Docetaxel in patients with relapsed or refractory metastatic colorectal adenocarcinoma with methylated CHFR and/or mi... not-yet-due
Ongoing 2015-001776-21 Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children not-yet-due
Not reported Terminated 2016-000304-29 Periocular and Intravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial 2018-03-28 due-trials
Ongoing 2017-003243-37 Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) Trial not-yet-due